3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 4
1
Status
Completed
2
Terminated
1
Sponsor Class
INDUSTRY
3
Study Type
Interventional
3
Sponsor
Cancer Type
Genitourinary
3
Conditions
Prostatic Neoplasms
112
Lymphoma
66
Lymphoma, Large B-Cell, Diffuse
50
Precursor Cell Lymphoblastic Leukemia-Lymphoma
31
Lymphoma, Non-Hodgkin
29
Lymphoma, Follicular
22
Burkitt Lymphoma
22
Multiple Myeloma
19
Leukemia
16
Hodgkin Disease
16
Neoplasms
14
Neoplasm Metastasis
13
Lymphoma, B-Cell
13
Lymphoma, Mantle-Cell
11
Lymphoma, Large-Cell, Anaplastic
11
Lymphoma, T-Cell
8
Lymphoma, B-Cell, Marginal Zone
8
Lymphoma, T-Cell, Peripheral
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Hematologic Neoplasms
5
Waldenstrom Macroglobulinemia
4
Recurrence
4
Lymphoma, Large-Cell, Immunoblastic
4
Lymphoma, AIDS-Related
4
Immunoblastic Lymphadenopathy
4
Prostate Cancer Metastatic
3
Primary Myelofibrosis
3
Polycythemia Vera
3
Plasmablastic Lymphoma
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Interventions
enzalutamide
3
cabazitaxel
3
Prednisone
3
Docetaxel
2
Abiraterone Acetate
2
rucaparib
1
Zuclomiphene
1
XRP6258
1
Standard of Care
1
LY3023414
1
Injections
1
Abituzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Has results
×
Prostate Cancer Metastatic
×
Prednisone
×
Clear all
NCT02485691
2022-05-27
CARD
Sanofi
Phase 4
Completed
255 enrolled
21 charts
NCT02379390
2019-06-21
PRIMCAB
Sanofi
Phase 2
Terminated
8 enrolled
8 charts
NCT01718353
2017-11-20
TAXYNERGY
Sanofi
Phase 2
Completed
63 enrolled
13 charts